Tang Capital Management LLC Atea Pharmaceuticals, Inc. Transaction History
Tang Capital Management LLC
- $1.17 Billion
- Q3 2024
A detailed history of Tang Capital Management LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 4,607,060 shares of AVIR stock, worth $14.3 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
4,607,060
Previous 4,476,741
2.91%
Holding current value
$14.3 Million
Previous $14.8 Million
4.15%
% of portfolio
1.31%
Previous 1.81%
Shares
5 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
52.4MCall Options Held
900Put Options Held
126K-
Black Rock Inc. New York, NY9.12MShares$28.3 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN6.65MShares$20.6 Million13.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$16.9 Million0.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$15 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.71 Million1.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $258M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...